Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Deyu Cai

Showing results (11-20 of 12) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 12 results.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|June 16, 2026
CauFinder: Steering Cell-State and Phenotype Transitions by Causal Disentanglement LearningChengming Zhang, Zexi Chen, Yuanxiang Miao, et al.
Medcomm|July 29, 2025
Camrelizumab, an Anti-PD-1 Monoclonal Antibody, Plus Carboplatin and Nab-Paclitaxel as First-Line Setting for Extensive-Stage Small-Cell Lung Cancer: A Phase 2 Trial and Biomarker AnalysisJia Yu, Deyu Cai, Sha Zhao, et al.
Pageof 2

Showing results (11-20 of 12) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 12 results.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|June 16, 2026
CauFinder: Steering Cell-State and Phenotype Transitions by Causal Disentanglement LearningChengming Zhang, Zexi Chen, Yuanxiang Miao, et al.
Medcomm|July 29, 2025
Camrelizumab, an Anti-PD-1 Monoclonal Antibody, Plus Carboplatin and Nab-Paclitaxel as First-Line Setting for Extensive-Stage Small-Cell Lung Cancer: A Phase 2 Trial and Biomarker AnalysisJia Yu, Deyu Cai, Sha Zhao, et al.
Pageof 2